Position in ZLAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,775,604
-$3,334,789 QoQ
Shares Held
94,397
-67.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in ZLAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. ZLAB ranks #222 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in ZLAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,775,604 | 94,397 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,110,393 | 289,705 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $4,062,730 | 119,880 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $10,109,857 | 289,101 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $95,212,960 | 2,634,559 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $82,942,313 | 3,166,946 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $41,384,576 | 1,714,357 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $9,424,294 | 543,814 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $4,240,635 | 264,709 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $7,951,278 | 290,936 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $6,012,856 | 247,341 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $6,694,600 | 241,421 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $11,149,114 | 335,211 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,830,369 | 255,061 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,449,158 | 188,572 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,545,703 | 246,416 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $6,422,439 | 146,031 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $14,333,379 | 228,057 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,791,574 | 159,328 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $20,274,024 | 114,549 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $15,562,873 | 116,637 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $10,675,888 | 78,882 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $10,416,625 | 125,245 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $9,882,044 | 120,322 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,233,511 | 23,961 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||